JPRN-jRCTc030220632招募中1 期
Multicenter clinical study of i.v. injected NKT cell therapy in patients with malignant tumors.
Goto Shigenori0 个研究点目标入组 6,000 人开始时间: 2023年2月10日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 6,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- •(1)Diagnostic imaging or Pathological diagnosis of malignant tumor.
- •(2)Informed consent has been obtained.
排除标准
- •(1)HIV Ab positive.
- •(2)T cell- or NK cell-originated leukemia and/or lymphoma.(LAK therapy)
- •(3)Patients who have previously treated allogenic transplantation.
- •(4)Responsible doctors judged the patient inappropriate for the clinical study.
研究者
相似试验
招募中
1 期
Multicenter clinical study of immune-cell therapy in patients with malignant tumors.malignant tumorJPRN-jRCTc030190254Goto Shigenori6,000
招募中
1 期
Multicenter clinical study of immune-cell therapy in patients with malignant tumors.JPRN-jRCTc030190255Goto Shigenori6,000
招募中
1 期
Multicenter clinical study of immune-cell therapy in patients with malignant tumors.malignant tumorJPRN-jRCTc030190249Goto Shigenori6,000
招募中
3 期
The effect of adding intravenous ketamine to Midazolam in reducing the need for analgesia after spinal anesthesia in elective cesarean sectioIRCT20211013052753N1Mashhad University of Medical Sciences40
招募中
1 期
Multicenter clinical study of immune-cell therapy in patients with malignant tumors.malignant tumorJPRN-jRCTc030220555Goto Shigenori6,000